Predicting overall survival in non-small cell lung cancer patients receiving concurrent radiochemotherapy and adjuvant durvalumab-a Polish real-world single-center experience.

Autor:	Łochowska, Barbara A.1,2 blochowska@op.pl, Stawiski, Konrad2,3, Kuna, Kasper3, Nowicka, Zuzanna3, Łochowski, Mariusz4, Fijuth, Jacek2
Zdroj:	Nowotwory. 2024, Vol. 74 Issue 3, p166-172. 7p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu